When life adds up: the cumulative burden of skin disease – 2025 Alan Cooper Epiderm Lecture

Join us for an engaging conversation on the topic of dermatology, led by Associate Professor Chris Baker and a panel of speakers, including those people directly impacted by chronic diseases to share their perspectives on the Cumulative Life Course Impairment (CLCI).

This concept is especially pertinent in dermatology, where chronic inflammatory skin conditions—such as psoriasis, atopic dermatitis, and hidradenitis suppurativa—often begin early in life, are visible, and significantly impact quality of life.

These conditions can cause persistent discomfort, psychological distress, and may contribute to systemic health issues, further increasing disease burden. CLCI highlights how the cumulative effects of disease-related stigma, symptoms, and comorbidities can limit opportunities and reduce life potential over time.

Despite past under recognition, acknowledging this impact is crucial to ensure patient access to effective therapies. Early and equitable access to care, guided by clinical and psychosocial indicators, is vital in altering disease trajectories. Proactive intervention can reduce CLCI risk and help patients achieve better long-term outcomes and life fulfilment.

Venue:  37 Kent Street, Woolloongabba, Brisbane. Room: Translational Research Institute Auditorium